-
141
Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines
Published 2017“…American Society of Hematology…”
Journal article -
142
Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations
Published 2018“…American Society of Hematology…”
Journal article -
143
Cell-Intrinsic Depletion of AML1-ETO-Positive Pre-Leukemic HSCs By Kras Activating Mutation
Published 2017“…American Society of Hematology…”
Conference item -
144
International Consensus Classification of myeloid neoplasms and acute leukemia: Integrating morphological, clinical, and genomic data.
Published 2022“…American Society of Hematology…”
Journal article -
145
Loss of COP9 signalosome gene-containing 2q region is associated with lenalidomide and pomalidomide resistance in myeloma patients
Published 2021“…American Society of Hematology…”
Conference item -
146
Loss of endothelial membrane KIT ligand affects systemic KIT ligand levels but not bone marrow hematopoietic stem cells
Published 2023“…American Society of Hematology…”
Journal article -
147
Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitro
Published 2022“…American Society of Hematology…”
Journal article -
148
Higher daunorubicin exposure benefits FLT3 mutated acute myeloid leukemia
Published 2016“…American Society of Hematology…”
Journal article -
149
Hypoxia-inducible factor 2α regulates key neutrophil functions in humans, mice, and zebrafish.
Published 2014“…American Society of Hematology…”
Journal article -
150
The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinib
Published 2019“…American Society of Hematology…”
Journal article -
151
Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia
Published 2020“…American Society of Hematology…”
Journal article -
152
Platelets kill circulating parasites of all major Plasmodium species in human malaria
Published 2018“…American Society of Hematology…”
Journal article -
153
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
Published 2018“…American Society of Hematology…”
Journal article -
154
Myeloproliferative neoplasm stem cells
Published 2017“…American Society of Hematology…”
Journal article -
155
Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma
Published 2020“…American Society of Hematology…”
Journal article -
156
Ruxolitinib versus best available therapy for ET intolerant or resistant to hydroxycarbamide in a randomized trial
Published 2017“…American Society of Hematology…”
Journal article -
157
Results of a phase 2 trial of the monocyte-targeted histone deacetylase inhibitor tefinostat (CHR-2845) in chronic myelomonocytic leukemia (CMML) - the UK monocle study
Published 2018“…American Society of Hematology…”
Conference item -
158
Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma.
Published 2013“…American Society of Hematology…”
Journal article -
159
A spiral scaffold underlies cytoadherent knobs in Plasmodium falciparum-infected erythrocytes
Published 2016“…American Society of Hematology…”
Journal article -
160
GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia.
Published 2013“…American Society of Hematology…”
Journal article